ArticleFrontiers in pharmacology2022

Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents.

Salma Bibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.